| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8244564 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 8 Pages |
Abstract
Conclusion: In the context of uncertainty about what constitutes optimal adjuvant treatment for resected NSCLC, PORT use has substantially declined.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Justin E. M.D., Kenneth E. M.D., Peter B. M.D., M.A.P.P., Deborah M.D., M.P.H.,